Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer.
Goshen-Lago T, Waldhorn I, Holland R, Szwarcwort-Cohen M, Reiner-Benaim A, Shachor-Meyouhas Y, Hussein K, Fahoum L, Baruch M, Peer A, Reiter Y, Almog R, Halberthal M, Ben-Aharon I.
Goshen-Lago T, et al. Among authors: baruch m.
JAMA Oncol. 2021 Oct 1;7(10):1507-1513. doi: 10.1001/jamaoncol.2021.2675.
JAMA Oncol. 2021.
PMID: 34236381
Free PMC article.